| Effect of continuous glucose monitoring on glycemic control in adolescents and young adults with type 1 diabetes: a randomized clinical trial LM Laffel, LG Kanapka, RW Beck, K Bergamo, MA Clements, A Criego, ... Jama 323 (23), 2388-2396, 2020 | 308 | 2020 |
| Use of insulin pump therapy in children and adolescents with type 1 diabetes and its impact on metabolic control: comparison of results from three large, transatlantic … JL Sherr, JM Hermann, F Campbell, NC Foster, SE Hofer, J Allgrove, ... Diabetologia 59 (1), 87-91, 2016 | 249 | 2016 |
| ISPAD clinical practice consensus guidelines 2018: diabetes technologies JL Sherr, M Tauschmann, T Battelino, M de Bock, G Forlenza, R Roman, ... Pediatr Diabetes 19 (Suppl 27), 302-325, 2018 | 246 | 2018 |
| Continuous glucose monitoring and glycemic control among youth with type 1 diabetes: International comparison from the T1D Exchange and DPV Initiative DJ DeSalvo, KM Miller, JM Hermann, DM Maahs, SE Hofer, MA Clements, ... Pediatric diabetes 19 (7), 1271-1275, 2018 | 224 | 2018 |
| American Association of Clinical Endocrinology clinical practice guideline: the use of advanced technology in the management of persons with diabetes mellitus G Grunberger, J Sherr, M Allende, T Blevins, B Bode, Y Handelsman, ... Endocrine practice 27 (6), 505-537, 2021 | 213 | 2021 |
| Consensus recommendations for the use of automated insulin delivery technologies in clinical practice M Phillip, R Nimri, RM Bergenstal, K Barnard-Kelly, T Danne, R Hovorka, ... Endocrine reviews 44 (2), 254-280, 2023 | 192 | 2023 |
| Continuous glucose monitoring profiles in healthy nondiabetic participants: a multicenter prospective study VN Shah, SN DuBose, Z Li, RW Beck, AL Peters, RS Weinstock, D Kruger, ... The Journal of Clinical Endocrinology & Metabolism 104 (10), 4356-4364, 2019 | 187 | 2019 |
| Multicenter trial of a tubeless, on-body automated insulin delivery system with customizable glycemic targets in pediatric and adult participants with type 1 diabetes SA Brown, GP Forlenza, BW Bode, JE Pinsker, CJ Levy, AB Criego, ... Diabetes Care 44 (7), 1630-1640, 2021 | 175 | 2021 |
| Effect of pramlintide on prandial glycemic excursions during closed-loop control in adolescents and young adults with type 1 diabetes SA Weinzimer, JL Sherr, E Cengiz, G Kim, JL Ruiz, L Carria, G Voskanyan, ... Diabetes care 35 (10), 1994-1999, 2012 | 161 | 2012 |
| Teplizumab treatment may improve C-peptide responses in participants with type 1 diabetes after the new-onset period: a randomised controlled trial KC Herold, SE Gitelman, SM Willi, PA Gottlieb, F Waldron-Lynch, ... Diabetologia 56, 391-400, 2013 | 154 | 2013 |
| Safety and glycemic outcomes during the MiniMed™ advanced hybrid closed-loop system pivotal trial in adolescents and adults with type 1 diabetes AL Carlson, JL Sherr, DI Shulman, SK Garg, R Pop-Busui, BW Bode, ... Diabetes technology & therapeutics 24 (3), 178-189, 2022 | 148 | 2022 |
| Reduced hypoglycemia and increased time in target using closed-loop insulin delivery during nights with or without antecedent afternoon exercise in type 1 diabetes JL Sherr, E Cengiz, CC Palerm, B Clark, N Kurtz, A Roy, L Carria, ... Diabetes care 36 (10), 2909-2914, 2013 | 141 | 2013 |
| A glycemia risk index (GRI) of hypoglycemia and hyperglycemia for continuous glucose monitoring validated by clinician ratings DC Klonoff, J Wang, D Rodbard, MA Kohn, C Li, D Liepmann, D Kerr, ... Journal of diabetes science and technology 17 (5), 1226-1242, 2023 | 137 | 2023 |
| Optimizing hybrid closed-loop therapy in adolescents and emerging adults using the MiniMed 670G system LH Messer, GP Forlenza, JL Sherr, RP Wadwa, BA Buckingham, ... Diabetes Care 41 (4), 789-796, 2018 | 137 | 2018 |
| Intranasal glucagon for treatment of insulin-induced hypoglycemia in adults with type 1 diabetes: a randomized crossover noninferiority study MR Rickels, KJ Ruedy, NC Foster, CA Piché, H Dulude, JL Sherr, ... Diabetes Care 39 (2), 264-270, 2016 | 135 | 2016 |
| Glucagon nasal powder: a promising alternative to intramuscular glucagon in youth with type 1 diabetes JL Sherr, KJ Ruedy, NC Foster, CA Piché, H Dulude, MR Rickels, ... Diabetes care 39 (4), 555-562, 2016 | 131 | 2016 |
| Effect of insulin feedback on closed-loop glucose control: a crossover study JL Ruiz, JL Sherr, E Cengiz, L Carria, A Roy, G Voskanyan, ... Journal of diabetes science and technology 6 (5), 1123-1130, 2012 | 119 | 2012 |
| High residual C-peptide likely contributes to glycemic control in type 1 diabetes MR Rickels, C Evans-Molina, HT Bahnson, A Ylescupidez, KJ Nadeau, ... The Journal of clinical investigation 130 (4), 1850-1862, 2020 | 105 | 2020 |
| Automated insulin delivery: benefits, challenges, and recommendations. A Consensus Report of the Joint Diabetes Technology Working Group of the European Association for the … JL Sherr, L Heinemann, GA Fleming, RM Bergenstal, D Bruttomesso, ... Diabetes Care 45 (12), 3058-3074, 2022 | 88 | 2022 |
| Effect of verapamil on pancreatic beta cell function in newly diagnosed pediatric type 1 diabetes: a randomized clinical trial GP Forlenza, J McVean, RW Beck, C Bauza, R Bailey, B Buckingham, ... Jama 329 (12), 990-999, 2023 | 86 | 2023 |
